Cargando…

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma

Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Chava, Srinivas, Reynolds, C. Patrick, Pathania, Anup S., Gorantla, Santhi, Poluektova, Larisa Y., Coulter, Don W., Gupta, Subash C., Pandey, Manoj K., Challagundla, Kishore B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944109/
https://www.ncbi.nlm.nih.gov/pubmed/31637848
http://dx.doi.org/10.1002/1878-0261.12588
_version_ 1783484996866015232
author Chava, Srinivas
Reynolds, C. Patrick
Pathania, Anup S.
Gorantla, Santhi
Poluektova, Larisa Y.
Coulter, Don W.
Gupta, Subash C.
Pandey, Manoj K.
Challagundla, Kishore B.
author_facet Chava, Srinivas
Reynolds, C. Patrick
Pathania, Anup S.
Gorantla, Santhi
Poluektova, Larisa Y.
Coulter, Don W.
Gupta, Subash C.
Pandey, Manoj K.
Challagundla, Kishore B.
author_sort Chava, Srinivas
collection PubMed
description Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk of recurrence. Thus, there is an urgent need for novel therapeutics. The deregulated expression of microRNA (miR) is reported in NB; nonetheless, its effect on MYCN regulation is poorly understood. First, we identified that miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p (hereafter miR‐15a, miR‐15b or miR‐16) were down‐regulated in patient‐derived xenografts (PDX) with high MYCN expression. MiR targeting sequences on MYCN mRNA were predicted using online databases such as TargetScan and miR database. The R2 database, containing 105 NB patients, showed an inverse correlation between MYCN mRNA and deleted in lymphocytic leukemia (DLEU) 2, a host gene of miR‐15. Moreover, overexpression of miR‐15a, miR‐15b or miR‐16 significantly reduced the levels of MYCN mRNA and N‐Myc protein. Conversely, inhibiting miR dramatically enhanced MYCN mRNA and N‐Myc protein levels, as well as increasing mRNA half‐life in NB cells. By performing immunoprecipitation assays of argonaute‐2 (Ago2), a core component of the RNA‐induced silencing complex, we showed that miR‐15a, miR‐15b and miR‐16 interact with MYCN mRNA. Luciferase reporter assays showed that miR‐15a, miR‐15b and miR‐16 bind with 3’UTR of MYCN mRNA, resulting in MYCN suppression. Moreover, induced expression of miR‐15a, miR‐15b and miR‐16 significantly reduced the proliferation, migration, and invasion of NB cells. Finally, transplanting miR‐15a‐, miR‐15b‐ and miR‐16‐expressing NB cells into NSG mice repressed tumor formation and MYCN expression. These data suggest that miR‐15a, miR‐15b and miR‐16 exert a tumor‐suppressive function in NB by targeting MYCN. Therefore, these miRs could be considered as potential targets for NB treatment.
format Online
Article
Text
id pubmed-6944109
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69441092020-01-07 miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma Chava, Srinivas Reynolds, C. Patrick Pathania, Anup S. Gorantla, Santhi Poluektova, Larisa Y. Coulter, Don W. Gupta, Subash C. Pandey, Manoj K. Challagundla, Kishore B. Mol Oncol Research Articles Neuroblastoma (NB) is the most common extracranial solid malignancy in children. Despite current aggressive treatment regimens, the prognosis for high‐risk NB patients remains poor, with the survival of less than 40%. Amplification/stabilization of MYCN oncogene, in NB is associated with a high risk of recurrence. Thus, there is an urgent need for novel therapeutics. The deregulated expression of microRNA (miR) is reported in NB; nonetheless, its effect on MYCN regulation is poorly understood. First, we identified that miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p (hereafter miR‐15a, miR‐15b or miR‐16) were down‐regulated in patient‐derived xenografts (PDX) with high MYCN expression. MiR targeting sequences on MYCN mRNA were predicted using online databases such as TargetScan and miR database. The R2 database, containing 105 NB patients, showed an inverse correlation between MYCN mRNA and deleted in lymphocytic leukemia (DLEU) 2, a host gene of miR‐15. Moreover, overexpression of miR‐15a, miR‐15b or miR‐16 significantly reduced the levels of MYCN mRNA and N‐Myc protein. Conversely, inhibiting miR dramatically enhanced MYCN mRNA and N‐Myc protein levels, as well as increasing mRNA half‐life in NB cells. By performing immunoprecipitation assays of argonaute‐2 (Ago2), a core component of the RNA‐induced silencing complex, we showed that miR‐15a, miR‐15b and miR‐16 interact with MYCN mRNA. Luciferase reporter assays showed that miR‐15a, miR‐15b and miR‐16 bind with 3’UTR of MYCN mRNA, resulting in MYCN suppression. Moreover, induced expression of miR‐15a, miR‐15b and miR‐16 significantly reduced the proliferation, migration, and invasion of NB cells. Finally, transplanting miR‐15a‐, miR‐15b‐ and miR‐16‐expressing NB cells into NSG mice repressed tumor formation and MYCN expression. These data suggest that miR‐15a, miR‐15b and miR‐16 exert a tumor‐suppressive function in NB by targeting MYCN. Therefore, these miRs could be considered as potential targets for NB treatment. John Wiley and Sons Inc. 2019-11-29 2020-01 /pmc/articles/PMC6944109/ /pubmed/31637848 http://dx.doi.org/10.1002/1878-0261.12588 Text en © 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Chava, Srinivas
Reynolds, C. Patrick
Pathania, Anup S.
Gorantla, Santhi
Poluektova, Larisa Y.
Coulter, Don W.
Gupta, Subash C.
Pandey, Manoj K.
Challagundla, Kishore B.
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title_full miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title_fullStr miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title_full_unstemmed miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title_short miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
title_sort mir‐15a‐5p, mir‐15b‐5p, and mir‐16‐5p inhibit tumor progression by directly targeting mycn in neuroblastoma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944109/
https://www.ncbi.nlm.nih.gov/pubmed/31637848
http://dx.doi.org/10.1002/1878-0261.12588
work_keys_str_mv AT chavasrinivas mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT reynoldscpatrick mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT pathaniaanups mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT gorantlasanthi mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT poluektovalarisay mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT coulterdonw mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT guptasubashc mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT pandeymanojk mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma
AT challagundlakishoreb mir15a5pmir15b5pandmir165pinhibittumorprogressionbydirectlytargetingmycninneuroblastoma